Literature DB >> 26116033

Mifepristone label laws and trends in use: recent experiences in four US states.

Wendy R Sheldon1, Beverly Winikoff2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26116033     DOI: 10.1016/j.contraception.2015.06.017

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


× No keyword cloud information.
  5 in total

1.  Rebound of medication abortion in Texas following updated mifepristone label.

Authors:  Sarah E Baum; Kari White; Kristine Hopkins; Joseph E Potter; Daniel Grossman
Journal:  Contraception       Date:  2019-01-23       Impact factor: 3.375

2.  Medication abortion use among low-income and rural Texans before and during state-imposed restrictions and after FDA-updated labeling.

Authors:  Vinita Goyal; Isabel H McLoughlin Brooks; Robin Wallace; Amna I Dermish; Bhavik Kumar; Ann Schutt-Ainé; Anitra Beasley; Abigail R A Aiken; Joseph E Potter
Journal:  Am J Obstet Gynecol       Date:  2020-02-25       Impact factor: 10.693

3.  Women's Experience Obtaining Abortion Care in Texas after Implementation of Restrictive Abortion Laws: A Qualitative Study.

Authors:  Sarah E Baum; Kari White; Kristine Hopkins; Joseph E Potter; Daniel Grossman
Journal:  PLoS One       Date:  2016-10-26       Impact factor: 3.240

4.  Comparison of Outcomes before and after Ohio's Law Mandating Use of the FDA-Approved Protocol for Medication Abortion: A Retrospective Cohort Study.

Authors:  Ushma D Upadhyay; Nicole E Johns; Sarah L Combellick; Julia E Kohn; Lisa M Keder; Sarah C M Roberts
Journal:  PLoS Med       Date:  2016-08-30       Impact factor: 11.069

5.  Sociodemographic Characteristics of Women Able to Obtain Medication Abortion Before and After Ohio's Law Requiring Use of the Food and Drug Administration Protocol.

Authors:  Ushma D Upadhyay; Nicole E Johns; Alice F Cartwright; Tanya E Franklin
Journal:  Health Equity       Date:  2018-07-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.